Europe Hospital at Home Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The Europe Hospital at Home Market size is expected to reach US$ 16,958.8 Million by 2034 from US$ 9,002.9 Million in 2025. The market is estimated to record a CAGR of 7.4% from 2026 to 2034.

Executive Summary and Europe Hospital at Home Market Analysis:

The hospital at home market in Europe is segmented into the UK, France, Italy, Spain, Switzerland, the Netherlands, Belgium, and the Rest of Europe. As per OECD's Health at a Glance: Europe 2024, telemonitoring, teleconsultation, and HaH programmes have confirmed reductions in congestive heart failure-related mortality and hospitalization risks, supporting shifts toward community-based alternatives amid declining inpatient beds across the EU. The number of HaH providers remains small but is growing across OECD countries, reflecting policy emphasis on sustainable care for multimorbidity in older adults.

France's long-established hospitalization a domicile (HAD) delivers millions of care days annually. The UK's NHS virtual wards scale nationally to manage frailty and respiratory conditions remotely. Spain's regional programs, particularly in Catalonia, with thousands of annual episodes, show comparable outcomes to inpatient care. Portugal's large-scale programme treated over 11,500 patients in 2024 via 'virtual' beds, underscoring HaH's role in easing overcrowding. Innovative care models across Europe incorporate expanded nursing roles and digital tools, as noted in WHO Europe analyses, to enhance transitional care and equity in rural areas. This trend aligns with EU priorities for resilient systems, promoting patient preference, reduced emissions, and cost efficiencies.

Europe Hospital at Home Market: Strategic Insights

Europe Hospital at Home Market Segmentation Analysis:

• By Component, the Europe Hospital at Home Market is segmented into Equipment and Devices and Software and Services. The Software and Services segment dominated the market in 2025.
• By Service Type, the Europe Hospital at Home Market is segmented into Acute Care at Home, Chronic Disease Management at Home, Post Acute or Transitional Care, Palliative Care and Hospice Care, and Rehabilitation Services. The Palliative Care and Hospice Care segment dominated the market in 2025.
• By Delivery Mode, the Europe Hospital at Home Market is segmented into Remote Monitoring and Telehealth, In-person Home Visits, and Hybrid Models. The Remote Monitoring and Telehealth segment dominated the market in 2025.
• By Patient Demographic, the Europe Hospital at Home Market is segmented into Adult Patients and Pediatric Patients. The Adult Patients segment dominated the market in 2025.
• By Indication, the Europe Hospital at Home Market is segmented into Cardiovascular Conditions, Respiratory Diseases, Orthopedic and Post-Surgical Recovery, Infectious Diseases, Neurological Rehabilitation, and Others. The Neurological Rehabilitation segment dominated the market in 2025.
• By Care Provider, the Europe Hospital at Home Market is segmented into Hospitals and Health Systems, Home Health Agencies, Primary Care or Physician Groups, and Private HaH Providers. The Hospitals and Health Systems segment dominated the market in 2025.

Europe Hospital at Home Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Hospital at Home Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Europe Hospital at Home Market Outlook

Globally, the average number of hospital beds per 1,000 people is nearly 2.9, according to international health statistics. High-income countries typically have higher bed densities than low- and middle-income countries. Data from the World Health Organization shows that changes to structural systems are taking place in healthcare systems that will help reduce the reliance on inpatient-type care by decreasing the number of hospital beds, with some systems reporting that their number of hospital beds per 1000 population has decreased from 13.0 to 8.9 beds per 1000 population over time. Many hospitals are under increased pressure to provide safe levels of occupancy with increased volume, an aging population, and shortages in the workforce. Approximately 15% of all hospital admissions are due to conditions that can be managed in an outpatient setting, resulting in a lack of efficiency related to the use of traditional hospitals. These circumstances are accelerating the demand for new ways of providing more efficient, large-scale delivery systems for health care outside of traditional hospital facilities.

These reductions arise from deliberate policy shifts toward outpatient services, day care, primary care gatekeeping, technological advances shortening inpatient stays, and reorganization into residential or community-based models, particularly in developed countries. HaH supports this transition by providing hospital-equivalent acute care at home, freeing physical beds for critical cases and alleviating overcrowding.

In the UK, NHS virtual wards-a form of HaH-have been expanded to manage patients remotely, adding capacity without new infrastructure and supporting survival rates comparable to inpatient care. In nations with significant bed cuts-such as Finland and Sweden-emphasis on community care aligns with HaH to handle elderly and chronic patients outside hospitals. This driver promotes HaH as a vital tool for maintaining service quality amid capacity constraints and evolving healthcare delivery priorities.

Europe Hospital at Home Market Country Insights

By country, the Europe Hospital at Home Market is segmented into Germany, the United Kingdom, France, Italy, Spain, the Netherlands, Switzerland, Belgium, and the Rest of Europe. Germany held the largest share in 2025.

Germany Hospital at Home (HaH) market is driven by an aging population and high healthcare costs. 22.1% of the population in Germany is over 65 slightly above the EU average of 21.1% in 2024 and projections indicate a 37% rise in long-term care needs by 2055 due to demographic changes. Germany is leveraging digital innovations to deliver acute care at home, reducing reliance on its extensive hospital infrastructure, which includes 7.8 beds per 1,000 inhabitants, far exceeding the EU average of 4.7. HaH initiatives focus on telemedicine and remote monitoring to manage chronic conditions such as heart failure and COPD, potentially addressing the country's high avoidable hospital admissions for such ailments, at 728 per 100,000 population in 2021, the highest in the EU. For instance, the Telemedicine Centre at Robert Bosch Hospital provides vital data monitoring and telephone support for chronic patients, while the Institute for Applied Telemedicine (IFAT) at the Heart and Diabetes Centre NRW serves around 11,000 individuals through heart failure telemonitoring programs. Another example is the TELnet@NRW project, which facilitates virtual consultations and has engaged over 20,000 patients since its launch, with funding of US$ 23.41 million from the Federal Joint Committee to optimize intensive care remotely. Supporting these efforts, the Digital Healthcare Act enables video consultations and prescribable health apps, while the 2023 Act to Accelerate Digitalization mandates electronic patient records from 2025 and e-prescriptions since 2024, enhancing home-based coordination. Long-term care spending, at 19% of health expenditure in 2021, underscores investment in home services, with 3.3 million people receiving care at home amid reforms such as hybrid DRGs that equalize reimbursements for outpatient procedures. Germany's Recovery and Resilience Plan allocate US$ 3.51 billion for hospital modernization, including telemedicine, positioning it as a leader in Europe's HaH evolution by integrating digital tools to cut costs and improve outcomes.

Europe Hospital at Home Market Company Profiles

Some of the key players operating in the market include B Braun SE, Medtronic Plc, Air Liquide, Huma Therapeutics Limited, Doccla, LNA-Santé, Inhealthcare, Spirit Health Group Ltd, RIBERA SALUD, and Capio Sverige AB.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Hospital at Home Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise